Table 2. Patients proportion of UCOD measured by death certificates only or by clinical and autopsy reports.
| Disease category | ICD-10 codes | Females (n = 187) | Males (n = 263) | ||||
| UCOD on the death certificates |
UCOD based on clinical and autopsy-derived information |
absolute differencea |
UCOD on the death certificates |
UCOD based on clinical and autopsy-derived information |
absolute differencea |
||
| Certain infectious and parasitic diseases | A00–B99 | 6 (3.2%) | 4 (2.1%) | −1.1% | 10 (3.8%) | 11 (4.2%) | 0.4% |
| Malignant neoplasms | C00–C97 | 62 (33.2%) | 72 (38.5%) | 5.3% | 94 (35.7%) | 110 (41.8%) | 6.1% |
| Malignant neoplasms of lip, oral cavity, and pharynx | C00–C14 | 0 (0.0%) | 0 (0.0%) | 0.0% | 0 (0.0%) | 1 (0.4%) | 0.4% |
| Malignant neoplasm of esophagus | C15 | 0 (0.0%) | 0 (0.0%) | 0.0% | 1 (0.4%) | 1 (0.4%) | 0.0% |
| Malignant neoplasm of stomach | C16 | 1 (0.5%) | 2 (1.1%) | 0.6% | 14 (5.3%) | 17 (6.5%) | 1.2% |
| Malignant neoplasm of colon | C18 | 4 (2.1%) | 4 (2.1%) | 0.0% | 2 (0.8%) | 2 (0.8%) | 0.0% |
| Malignant neoplasm of rectum and rectosigmoid junction | C19–C20 | 1 (0.5%) | 1 (0.5%) | 0.0% | 2 (0.8%) | 2 (0.8%) | 0.0% |
| Malignant neoplasm of liver and intrahepatic bile ducts | C22 | 2 (1.1%) | 5 (2.7%) | 1.6% | 4 (1.5%) | 5 (1.9%) | 0.4% |
| Malignant neoplasm of gallbladder and unspecified parts of biliary tract |
C23–C24 | 5 (2.7%) | 8 (4.3%) | 1.6% | 3 (1.1%) | 5 (1.9%) | 0.8% |
| Malignant neoplasm of pancreas | C25 | 4 (2.1%) | 3 (1.6%) | −0.5% | 4 (1.5%) | 5 (1.9%) | 0.4% |
| Malignant neoplasm of trachea, bronchus, and lung | C33–C34 | 14 (7.5%) | 13 (7.0%) | −0.5% | 26 (9.9%) | 31 (11.8%) | 1.9% |
| Malignant neoplasm of cervix uteri, corpus uteri, and uterus | C53–C55 | 1 (0.5%) | 1 (0.5%) | 0.0% | — | — | — |
| Malignant neoplasm of prostate | C61 | — | — | — | 1 (0.4%) | 0 (0.0%) | −0.4% |
| Malignant neoplasm of bladder | C67 | 3 (1.6%) | 1 (0.5%) | −1.1% | 1 (0.4%) | 1 (0.4%) | 0.0% |
| Malignant lymphoma | C81–C85 | 11 (5.9%) | 13 (7.0%) | 1.1% | 8 (3.0%) | 11 (4.2%) | 1.2% |
| Leukemia | C91–C95 | 10 (5.3%) | 16 (8.6%) | 3.3% | 23 (8.7%) | 24 (9.1%) | 0.40% |
| Other malignant neoplasms | Others in C00–C97 | 6 (3.2%) | 5 (2.7%) | −0.5% | 5 (1.9%) | 5 (1.9%) | 0.0% |
| Non-malignant neoplasms | D00–D48 | 6 (3.2%) | 1 (0.5%) | −2.7% | 3 (1.1%) | 5 (1.9%) | 0.8% |
| Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | D50–D89 | 1 (0.5%) | 2 (1.1%) | 0.6% | 3 (1.1%) | 3 (1.1%) | 0.0% |
| Endocrine, nutritional, and metabolic diseases | E00–E90 | 1 (0.5%) | 6 (3.2%) | 2.7% | 5 (1.9%) | 5 (1.9%) | 0.0% |
| Diabetes mellitus | E10–E14 | 1 (0.5%) | 2 (1.1%) | 0.6% | 2 (0.8%) | 3 (1.1%) | 0.3% |
| Other endocrine, nutritional, and metabolic diseases | Others in E00–E90 | 0 (0.0%) | 4 (2.1%) | 2.1% | 3 (1.1%) | 2 (0.8%) | −0.3% |
| Mental and behavioral disorders | F00–F99 | 0 (0.0%) | 1 (0.5%) | 0.5% | 0 (0.0%) | 0 (0.0%) | 0.0% |
| Diseases of the nervous system | G00–G99 | 5 (2.7%) | 6 (3.2%) | 0.5% | 4 (1.5%) | 7 (2.7%) | 1.2% |
| Diseases of the circulatory system | I00–I99 | 46 (24.6%) | 52 (27.8%) | 3.2% | 41 (15.6%) | 45 (17.1%) | 1.5% |
| Hypertensive diseases | I10–I15 | 1 (0.5%) | 0 (0.0%) | −0.5% | 2 (0.8%) | 0 (0.0%) | −0.8% |
| Heart disease | I01–I02, I05–I09, I20–I25, I27, I30–I52 | 26 (13.9%) | 34 (18.2%) | 4.3% | 27 (10.3%) | 33 (12.5%) | 2.2% |
| Cerebrovascular diseases | I60–I69 | 9 (4.8%) | 6 (3.2%) | −1.6% | 4 (1.5%) | 2 (0.8%) | −0.7% |
| Aortic aneurysm and dissection | I71 | 5 (2.7%) | 6 (3.2%) | 0.5% | 4 (1.5%) | 6 (2.3%) | 0.8% |
| Diseases of the circulatory system other than aortic aneurysm and dissection | Others in I00–I99 | 5 (2.7%) | 6 (3.2%) | 0.5% | 4 (1.5%) | 4 (1.5%) | 0.0% |
| Diseases of the respiratory system | J00–J99 | 29 (16.5%) | 17 (9.1%) | −7.4% | 70 (26.6%) | 51 (19.3%) | −7.3% |
| Pneumonia | J12–J18 | 20 (10.7%) | 8 (4.3%) | −6.4% | 37 (14.1%) | 14 (5.3%) | −8.8% |
| Chronic obstructive pulmonary disease | J41–J44 | 2 (1.1%) | 0 (0.0%) | −1.1% | 11 (4.2%) | 11 (4.2%) | 0.0% |
| Other diseases of the respiratory system | Others in J00–J99 | 7 (3.7%) | 9 (4.8%) | 1.1% | 22 (8.4%) | 26 (9.9%) | 1.5% |
| Diseases of the digestive system | K00–K93 | 16 (8.6%) | 14 (7.5%) | −1.1% | 15 (5.7%) | 13 (4.9%) | −0.8% |
| Diseases of the skin and subcutaneous tissue | L00–L99 | 0 (0.0%) | 1 (0.5%) | 0.5% | 1 (0.4%) | 0 (0.0%) | −0.4% |
| Diseases of the musculoskeletal system and connective tissue | M00–M99 | 1 (0.5%) | 5 (2.7%) | 2.2% | 1 (0.4%) | 1 (0.4%) | 0.0% |
| Diseases of the genitourinary system | N00–N99 | 7 (3.7%) | 5 (2.7%) | −1.0% | 4 (1.5%) | 6 (2.3%) | 0.8% |
| Other cause of death | Others | 7 (3.7%) | 1 (0.5%) | −3.2% | 12 (4.6%) | 6 (2.3%) | −2.3% |
UCOD, underlying cause of death.
aThe difference between the proportion of UCOD based on clinical and autopsy-derived information and that of UCOD on the death certificates.